Literature DB >> 23563790

Effects of atelocollagen on neural stem cell function and its migrating capacity into brain in psychiatric disease model.

Toshihiro Yoshinaga1, Eri Hashimoto, Wataru Ukai, Takao Ishii, Tomohiro Shirasaka, Yoshiyasu Kigawa, Masaru Tateno, Hiroo Kaneta, Kimihiko Watanabe, Takeshi Igarashi, Seiju Kobayashi, Hitoshi Sohma, Tadafumi Kato, Toshikazu Saito.   

Abstract

Stem cell therapy is well proposed as a potential method for the improvement of neurodegenerative damage in the brain. Among several different procedures to reach the cells into the injured lesion, the intravenous (IV) injection has benefit as a minimally invasive approach. However, for the brain disease, prompt development of the effective treatment way of cellular biodistribution of stem cells into the brain after IV injection is needed. Atelocollagen has been used as an adjunctive material in a gene, drug and cell delivery system because of its extremely low antigenicity and bioabsorbability to protect these transplants from intrabody environment. However, there is little work about the direct effect of atelocollagen on stem cells, we examined the functional change of survival, proliferation, migration and differentiation of cultured neural stem cells (NSCs) induced by atelocollagen in vitro. By 72-h treatment 0.01-0.05% atelocollagen showed no significant effects on survival, proliferation and migration of NSCs, while 0.03-0.05% atelocollagen induced significant reduction of neuronal differentiation and increase of astrocytic differentiation. Furthermore, IV treated NSCs complexed with atelocollagen (0.02%) could effectively migrate into the brain rather than NSC treated alone using chronic alcohol binge model rat. These experiments suggested that high dose of atelocollagen exerts direct influence on NSC function but under 0.03% of atelocollagen induces beneficial effect on regenerative approach of IV administration of NSCs for CNS disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23563790     DOI: 10.1007/s00702-013-1010-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  40 in total

1.  Comparative phenotypic analysis of articular chondrocytes cultured within type I or type II collagen scaffolds.

Authors:  Anne-Marie Freyria; Marie-Claire Ronzière; Delphine Cortial; Laurent Galois; Daniel Hartmann; Daniel Herbage; Frédéric Mallein-Gerin
Journal:  Tissue Eng Part A       Date:  2009-06       Impact factor: 3.845

Review 2.  Cell therapy in Parkinson's disease.

Authors:  Olle Lindvall; Anders Björklund
Journal:  NeuroRx       Date:  2004-10

Review 3.  Cell therapy for spinal cord injury by neural stem/progenitor cells derived from iPS/ES cells.

Authors:  Osahiko Tsuji; Kyoko Miura; Kanehiro Fujiyoshi; Suketaka Momoshima; Masaya Nakamura; Hideyuki Okano
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

4.  Comparative study of methods for administering neural stem/progenitor cells to treat spinal cord injury in mice.

Authors:  Yuichiro Takahashi; Osahiko Tsuji; Gentaro Kumagai; Chikako Miyauchi Hara; Hirotaka James Okano; Atsushi Miyawaki; Yoshiaki Toyama; Hideyuki Okano; Masaya Nakamura
Journal:  Cell Transplant       Date:  2010-11-05       Impact factor: 4.064

5.  SDF-1/CXCR4 axis modulates bone marrow mesenchymal stem cell apoptosis, migration and cytokine secretion.

Authors:  Xiaolei Liu; Biyan Duan; Zhaokang Cheng; Xiaohua Jia; Lina Mao; Hao Fu; Yongzhe Che; Lailiang Ou; Lin Liu; Deling Kong
Journal:  Protein Cell       Date:  2011-11-06       Impact factor: 14.870

6.  Prospective isolation of cortical interneuron precursors from mouse embryonic stem cells.

Authors:  Asif Mirza Maroof; Keith Brown; Song-Hai Shi; Lorenz Studer; Stewart A Anderson
Journal:  J Neurosci       Date:  2010-03-31       Impact factor: 6.167

7.  Atelocollagen-mediated systemic DDS for nucleic acid medicines.

Authors:  Koji Hanai; Fumitaka Takeshita; Kimi Honma; Shunji Nagahara; Miho Maeda; Yoshiko Minakuchi; Akihiko Sano; Takahiro Ochiya
Journal:  Ann N Y Acad Sci       Date:  2006-10       Impact factor: 5.691

8.  Differentiation of mesenchymal stem cells into osteoblasts on honeycomb collagen scaffolds.

Authors:  Joseph George; Yoshinori Kuboki; Teruo Miyata
Journal:  Biotechnol Bioeng       Date:  2006-10-20       Impact factor: 4.530

9.  Toxicity of organotin compounds in primary cultures of rat cortical astrocytes.

Authors:  C Röhl; M Gülden; H Seibert
Journal:  Cell Biol Toxicol       Date:  2001       Impact factor: 6.691

10.  Neural cell adhesion molecule polysialylation enhances the sensitivity of embryonic stem cell-derived neural precursors to migration guidance cues.

Authors:  Tamara Glaser; Claudia Brose; Isabelle Franceschini; Katja Hamann; Alina Smorodchenko; Frauke Zipp; Monique Dubois-Dalcq; Oliver Brüstle
Journal:  Stem Cells       Date:  2007-09-06       Impact factor: 6.277

View more
  2 in total

1.  Stem cell therapy: a new approach to the treatment of refractory depression.

Authors:  Yoshiyasu Kigawa; Eri Hashimoto; Wataru Ukai; Takao Ishii; Kengo Furuse; Hanako Tsujino; Tomohiro Shirasaka; Toshikazu Saito
Journal:  J Neural Transm (Vienna)       Date:  2014-03-27       Impact factor: 3.575

2.  Intra-cerebral implantation of a variety of collagenous scaffolds with nervous embryonic cells.

Authors:  Jacek Drobnik; Krystyna Pietrucha; Karolina Janczar; Lech Polis; Bartosz Polis; Marta Safandowska; Jacek Szymański
Journal:  Exp Ther Med       Date:  2019-10-21       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.